Trial intelligence / Profile preview

Ovarian Suppression with Gestodene/Ethinyl Estradiol Patch

NCT02550977Phase 2Completed

Sponsor
Bayer
Start
Sep 2015
Primary completion
Jul 2016
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of ethinyl estradiol, gestodene in pregnancy, sponsored by Bayer. Started Sep 2015; status: completed.

02

Drugs

ethinyl estradiolgestodene
03

Conditions

pregnancy

Beyond the preview

Go deeper on NCT02550977.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02550977.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call